137813-36-6 Usage
General Description
CYCLO(-ARG-ALA-ASP-D-PHE-VAL) is a cyclic peptide consisting of the amino acid sequence arginine-alanine-aspartic acid-D-phenylalanine-valine. This peptide has been studied for its potential therapeutic applications, particularly in the field of drug design and development. The unique cyclic structure of CYCLO(-ARG-ALA-ASP-D-PHE-VAL) may confer increased stability and bioavailability compared to linear peptides, making it an attractive candidate for pharmaceutical use. Research into the biological activity and potential medicinal properties of this compound is ongoing, with a focus on its ability to target specific cellular receptors or pathways for the treatment of various diseases and disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 137813-36-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,7,8,1 and 3 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 137813-36:
(8*1)+(7*3)+(6*7)+(5*8)+(4*1)+(3*3)+(2*3)+(1*6)=136
136 % 10 = 6
So 137813-36-6 is a valid CAS Registry Number.
137813-36-6Relevant articles and documents
METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS
-
Page/Page column 16, (2008/06/13)
The present invention describes methods for inhibiting angiogenesis in tissues using vitronectin alpha v beta 5 antagonists. The alpha v beta 5-mediated angiogenesis is correlated with exposure to cytokines including vascular endothelial growth factor, transforming growth factor- alpha and epidermal growth factor. Inhibition of alpha v beta 5-mediated angiogenesis is particularly preferred in vascular endothelial ocular neovascular diseases, in tumor growth and in inflammatory conditions, using therapeutic compositions containing alpha v beta 5 antagonists.
